TANVEER CHAUDHRY: Open Payments
NPI 1932195823 · BROOKSVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,475 in 63 payments from 13 companies in 2025. Trend: 2023 $2,900 · 2024 $2,763 · 2025 $1,475
Food & beverage: $1,475
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 6 | $197 |
| Otsuka America Pharmaceutical, Inc. | 10 | $168 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $159 |
| Alkermes, Inc. | 8 | $158 |
| Lundbeck LLC | 8 | $147 |
| ABBVIE INC. | 5 | $125 |
| Neurocrine BioSciences, Inc. | 5 | $120 |
| E.R. Squibb & Sons, L.L.C. | 5 | $109 |
| Axsome Therapeutics, Inc. | 4 | $83 |
| Teva Pharmaceuticals USA, Inc. | 3 | $71 |
Products named: REXULTI, SPRAVATO, CAPLYTA, ARISTADA, VRAYLAR, INGREZZA, COBENFY, Auvelity.
Industry payments across FL — which companies pay providers there.
